EGRX  valuation analysis

Basics
Name: Eagle Pharmaceuticals, Inc
Description: Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 10, 2021
Market cap: $618.10M (1353rd)
Sales(TTM): $183.03M (1363rd)
Earnings(TTM): $14.44M (1079th)

Value
FFER: 0.80 (why)
Actual price: $47.02
FFEThis is Eagle Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $58.77
Quantile: EGRX is priced correctly given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry